| Industry's view on using quality control, biorelevant, and clinically relevant dissolution tests for pharmaceutical development, registration, and commercialization H Grady, D Elder, GK Webster, Y Mao, Y Lin, T Flanagan, J Mann, ... Journal of pharmaceutical sciences 107 (1), 34-41, 2018 | 86 | 2018 |
| Dissolution testing in drug product development: workshop summary report A Abend, D Curran, J Kuiper, X Lu, H Li, A Hermans, P Kotwal, DA Diaz, ... The AAPS Journal 21, 1-12, 2019 | 29 | 2019 |
| In vitro release test methods for drug formulations for parenteral applications V Gray, S Cady, D Curran, J DeMuth, O Eradiri, M Hussain, J Krämer, ... Dissolution Technol 25 (4), 8-13, 2018 | 21 | 2018 |
| Evaluating parameters affecting drug fate at the intramuscular injection site AJS McCartan, DW Curran, RJ Mrsny Journal of Controlled Release 336, 322-335, 2021 | 9 | 2021 |
| Drug Dissolution in Oral Drug Absorption: Workshop Report K Raines, P Agarwal, P Augustijns, A Alayoubi, L Attia, A Bauer-Brandl, ... The AAPS Journal 25 (6), 103, 2023 | 6 | 2023 |
| Modelling intramuscular drug fate in vitro with tissue-relevant biomimetic hydrogels A McCartan, J Mackay, D Curran, RJ Mrsny International Journal of Pharmaceutics: X 4, 100125, 2022 | 4 | 2022 |
| Dissolution methodologies from biorelevant to quality control: challenges and gaps X Lu, JH Han, D Mattocks Dissolution and translational modeling strategies enabling patientcentric …, 2017 | 2 | 2017 |
| Accelerated stability modeling: An ionic liquid drug product D Clancy, J Campbell, D Curran, S Rusk Accelerated Predictive Stability, 411-448, 2018 | 1 | 2018 |
| Bioequivalence study with lapatinib powder for oral suspension and the original tablet formulation in cancer patients KM Koch, G Ferron‐Brady, C Lemmon, L Cartee, H Hollyfield, ... Clinical Pharmacology in Drug Development 4 (3), 203-209, 2015 | 1 | 2015 |
| Impact of Vessel Inner Diameter in USP Dissolution Apparatus 2 D Curran, GN Grove, M Tsundupalli, X Zhang | | 2024 |
| Chapter 20 - Accelerated Stability Modeling: An Ionic Liquid Drug Product SR Don Clancy, John Campbell, David Curran Accelerated Predictive Stability (APS): Fundamentals and Pharmaceutical …, 2018 | | 2018 |
| Dissolution Methodologies from Biorelevant to Quality Control: Bridging the Gaps X Lu, JH Han, D Mattocks, D Curran AAPS Newsmagazine 20 (9), 14-17, 2017 | | 2017 |
| 290 THE INTERSYSTEM MODEL M Chernovetz, S Chess, N Chodorow, M Chrisman, JVE Coeling, ... The Intersystem Model: Integrating Theory and Practice, 289, 1997 | | 1997 |
| ESTÍMULO AL PROCESO DE REVISIÓN V Gray, S Cady, D Curran, J DeMuth, O Eradiri, M Hussain, J Krämer, ... | | |
